Prognostic implications of systemic immune-inflammation index in patients with bone metastases from hepatocellular carcinoma treated with radiotherapy

Prognostic implications of systemic immune-inflammation index in patients with bone metastases from hepatocellular carcinoma treated with radiotherapy

BackgroundPrevious studies have shown that systemic inflammation indicators could predict the survival outcomes of patients with malignant tumors receiving various treatments. Radiotherapy, as a crucial treatment modality, effectively alleviates discomfort in patients with bone metastasis (BM) and g...

Full description

Bibliographic Details
Main Authors:	Jingyao Chen, Wenhan Huang, Xiaohong Xu, Shaonan Fan, Qi Zhang, Xuan Li, Zhaochong Zeng, Jian He
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-05-01
Series:	Frontiers in Oncology
Subjects:	hepatocellular carcinoma bone metastasis radiotherapy systemic immune-inflammation index prognostic value
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2023.1076428/full

Similar Items

Establishment and validation of a prognostic pomogram in unresectable hepatocellular carcinoma treated with intensity modulated radiotherapy: a real world study
by: Meiying Long, et al.
Published: (2023-06-01)

Efficacy of Liver-Directed Combined Radiotherapy in Locally Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
by: Jina Kim, et al.
Published: (2023-06-01)

Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma after liver transplantation
by: He Jian, et al.
Published: (2011-11-01)

Theraputic Effect and Quality of Life Assessment in Patients with Neuropathic Pain Due to Bone Metastasis from Hepatocellular Carcinoma Treated with Radiotherapy and Pregabalin
by: TONG Jinlong, et al.
Published: (2023-12-01)

Skull Base Metastasis from Hepatocellular Carcinoma: Clinical Presentation and Efficacy of Radiotherapy
by: Kim K, et al.
Published: (2022-04-01)

Evaluation of the Clinical Efficacy of Intensity-Modulated Radiotherapy Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma with Extrahepatic Oligometastasis and Prognostic Factors for Patient Survival
by: Luo Y, et al.
Published: (2023-04-01)

The association between graded prognostic assessment and the prognosis of brain metastases after whole brain radiotherapy: a meta-analysis
by: Xiaohan Geng, et al.
Published: (2024-01-01)

The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
by: Kinoshita Akiyoshi, et al.
Published: (2013-02-01)

Prognostic Factors Influencing Survival and a Treatment Pattern Analysis of Conventional Palliative Radiotherapy for Patients with Bone Metastases
by: Patricia Ignat, et al.
Published: (2021-10-01)

Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study
by: Kenji Makita, et al.
Published: (2021-11-01)

An easy tool to predict survival in patients with bone metastatic lung cancer treated with palliative radiotherapy
by: Kenji Makita, et al.
Published: (2023-07-01)

Factors Affecting Survival and Local Control in Patients with Bone Metastases Treated with Radiotherapy
by: Kenji Makita, et al.
Published: (2023-02-01)

Radiotherapy for metastatic fibrolamellar hepatocellular carcinoma
by: Justin G. Peacock, et al.
Published: (2013-07-01)

Identification of a prognostic cuproptosis-related signature in hepatocellular carcinoma
by: Yuqiao Chen, et al.
Published: (2023-02-01)

Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors
by: Jiang Xiao-Bing, et al.
Published: (2012-02-01)

Risk and prognostic nomograms for hepatocellular carcinoma with newly-diagnosed pulmonary metastasis using SEER data
by: Guanzhi Ye, et al.
Published: (2019-08-01)

Volumetric reduction of brain metastases after stereotactic radiotherapy: Prognostic factors and effect on local control
by: Naoyuki Kanayama, et al.
Published: (2022-12-01)

Advances in radiotherapy and immunity in hepatocellular carcinoma
by: Yuhan Yang, et al.
Published: (2023-08-01)

Prognosticators of hepatocellular carcinoma with intrahepatic vascular invasion
by: Yuan-Chen Lo, et al.
Published: (2019-01-01)

Nursing care for patients with bone metastases undergoing radiotherapy: a scoping review
by: Taís dos Passos Sagica, et al.
Published: (2023-03-01)

Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab
by: Tae Hyun Kim, et al.
Published: (2023-09-01)

Survival Outcomes and Prognostic Factors in Salivary Gland Cancers Treated by Surgery and Adjuvant Radiotherapy
by: Mürsel DÜZOVA, et al.
Published: (2021-08-01)

Carbon Ion Radiotherapy in the Treatment of Hepatocellular Carcinoma
by: Hwa Kyung Byun, et al.
Published: (2023-10-01)

Long-term survival after multimodal treatment involving radiotherapy for huge hepatocellular carcinoma with oligometastasis: a case report
by: Byung Min Lee, et al.
Published: (2021-09-01)

Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
by: Chuan Hu, et al.
Published: (2020-06-01)

Current status of stereotactic body radiotherapy for the treatment of hepatocellular carcinoma
by: Jongmoo Park, et al.
Published: (2019-09-01)

The Role of Radical Dose of Radiotherapy in Hepatocellular Carcinoma
by: Maher Soliman
Published: (2022-07-01)

Skeletal Muscle Depletion Predicts the Prognosis of Patients With Hepatocellular Carcinoma Treated With Radiotherapy
by: Joongyo Lee, et al.
Published: (2019-10-01)

Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling
by: Zongjuan Li, et al.
Published: (2022-12-01)

Bone metastases: an overview
by: Filipa Macedo, et al.
Published: (2017-05-01)

Patterns of Bone Failure in Localized Prostate Cancer Previously Irradiated: The Preventive Role of External Radiotherapy on Pelvic Bone Metastases
by: Mathieu Grapin, et al.
Published: (2019-02-01)

Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy
by: Binwei Lin, et al.
Published: (2020-04-01)

Diabetes Mellitus Is a Strong Independent Negative Prognostic Factor in Patients with Brain Metastases Treated with Radiotherapy
by: Seong Jeong, et al.
Published: (2023-10-01)

Prognostic factors and a new scoring system for survival of patients irradiated for bone metastases
by: Dirk Rades, et al.
Published: (2019-11-01)

Palliative intensity modulated radiotherapy of bone metastases based on diagnostic instead of planning computed tomography scans
by: Suvi Larjavaara, et al.
Published: (2023-07-01)

Identification and Validation of TYMS as a Potential Biomarker for Risk of Metastasis Development in Hepatocellular Carcinoma
by: Shuai Li, et al.
Published: (2021-11-01)

Carbon ion radiotherapy for 80 years or older patients with hepatocellular carcinoma
by: Shintaro Shiba, et al.
Published: (2017-11-01)

Survival and effective prognostic factors in lung cancer patients with brain metastases treated with whole brain radiotherapy
by: Bixin Ren, et al.
Published: (2021-03-01)

Vertebral compression fracture after stereotactic ablative radiotherapy in patients with oligometastatic bone lesions from hepatocellular carcinoma
by: Tae Hyung Kim, et al.
Published: (2023-07-01)

Strategic application of radiotherapy for hepatocellular carcinoma
by: Seo Hee Choi, et al.
Published: (2018-06-01)